NASDAQ:SLS   SELLAS Life Sciences Group, Inc.
SLS was sold off hard the last two days despite positive news. The current price has acted as both support and resistance in recent months (shaded area).

With an RSI of 38 and the price well bellow the POC line (90 days) I think 9.08 may have been the bottom. I think the drop had more to do with large investors rebalancing for the 2nd half of the year than anything else.

I would like to see the price close above the 50SMA to enter for a long swing trade.

Targeting 12.89 in the short term.

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.